Literature DB >> 24771855

Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema.

Mikell Paige1, Kan Wang2, Marie Burdick3, Sunhye Park3, Josiah Cha3, Erin Jeffery4, Nicholas Sherman4, Y Michael Shim5.   

Abstract

The leukotriene A4 hydrolase (LTA4H) is a bifunctional enzyme with epoxy hydrolase and aminopeptidase activities. We hypothesize that the LTA4H aminopeptidase activity alleviates neutrophilic inflammation, which contributes to cigarette smoke (CS)-induced emphysema by clearing proline-glycine-proline (PGP), a triamino acid chemokine known to induce chemotaxis of neutrophils. To investigate the biological contributions made by the LTA4H aminopeptidase activity in CS-induced emphysema, we exposed wild-type mice to CS over 5 mo while treating them with a vehicle or a pharmaceutical agent (4MDM) that selectively augments the LTA4H aminopeptidase without affecting the bioproduction of leukotriene B4. Emphysematous phenotypes were assessed by premortem lung physiology with a small animal ventilator and by postmortem histologic morphometry. CS exposure acidified the airspaces and induced localization of the LTA4H protein into the nuclei of the epithelial cells. This resulted in accumulation of PGP in the airspaces by suppressing the LTA4H aminopeptidase activity. When the LTA4H aminopeptidase activity was selectively augmented by 4MDM, the levels of PGP in the bronchoalveolar lavage fluid and infiltration of neutrophils into the lungs were significantly reduced without affecting the levels of leukotriene B4. This protected murine lungs from CS-induced emphysematous alveolar remodeling. In conclusion, CS exposure promotes the development of CS-induced emphysema by suppressing the enzymatic activities of the LTA4H aminopeptidase in lung tissues and accumulating PGP and neutrophils in the airspaces. However, restoring the leukotriene A4 aminopeptidase activity with a pharmaceutical agent protected murine lungs from developing CS-induced emphysema.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771855      PMCID: PMC4083682          DOI: 10.4049/jimmunol.1400452

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  [Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease].

Authors:  José Luis Izquierdo; Carlos Almonacid; Trinidad Parra; Jaime Pérez
Journal:  Arch Bronconeumol       Date:  2006-07       Impact factor: 4.872

2.  Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.

Authors:  W G Roberts; T J Simon; R G Berlin; R C Haggitt; E S Snyder; W F Stenson; S B Hanauer; J E Reagan; A Cagliola; W K Tanaka; S Simon; M L Berger
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

3.  A CXCL8 receptor antagonist based on the structure of N-acetyl-proline-glycine-proline.

Authors:  Patricia L Jackson; Brett D Noerager; Michael J Jablonsky; Matthew T Hardison; Bryan D Cox; James C Patterson; Boopathy Dhanapal; J Edwin Blalock; Donald D Muccio
Journal:  Eur J Pharmacol       Date:  2011-03-31       Impact factor: 4.432

4.  Time course of cigarette smoke-induced pulmonary inflammation in mice.

Authors:  A I D'hulst; K Y Vermaelen; G G Brusselle; G F Joos; R A Pauwels
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

5.  Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.

Authors:  Marjolein M G M Thunnissen; Björn Andersson; Bengt Samuelsson; Chi-Huey Wong; Jesper Z Haeggström
Journal:  FASEB J       Date:  2002-08-07       Impact factor: 5.191

6.  Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models.

Authors:  Pär Bjelkmar; Per Larsson; Michel A Cuendet; Berk Hess; Erik Lindahl
Journal:  J Chem Theory Comput       Date:  2010-01-25       Impact factor: 6.006

7.  A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation.

Authors:  Nathaniel M Weathington; Anneke H van Houwelingen; Brett D Noerager; Patricia L Jackson; Aletta D Kraneveld; F Shawn Galin; Gert Folkerts; Frans P Nijkamp; J Edwin Blalock
Journal:  Nat Med       Date:  2006-02-12       Impact factor: 53.440

Review 8.  Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease.

Authors:  Justin B Usery; Timothy H Self; Muthiah P Muthiah; Christopher K Finch
Journal:  Pharmacotherapy       Date:  2008-09       Impact factor: 4.705

9.  Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.

Authors:  Douglas R Davies; Bjorn Mamat; Olafur T Magnusson; Jeff Christensen; Magnus H Haraldsson; Rama Mishra; Brian Pease; Erik Hansen; Jasbir Singh; David Zembower; Hidong Kim; Alex S Kiselyov; Alex B Burgin; Mark E Gurney; Lance J Stewart
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

10.  N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD.

Authors:  Philip O'Reilly; Patricia L Jackson; Brett Noerager; Suzanne Parker; Mark Dransfield; Amit Gaggar; J Edwin Blalock
Journal:  Respir Res       Date:  2009-05-18
View more
  12 in total

1.  Leukotriene A4 hydrolase: the Janus enzyme shows its ugly side in smokers.

Authors:  Robert Snelgrove; Farrah Kheradmand
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

2.  Genome-Wide Association Analysis of Single-Breath DlCO.

Authors:  Phuwanat Sakornsakolpat; Meredith McCormack; Per Bakke; Amund Gulsvik; Barry J Make; James D Crapo; Michael H Cho; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2019-05       Impact factor: 6.914

3.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Decrease Lung Injury in Mice.

Authors:  Qi Hao; Varun Gudapati; Antoine Monsel; Jeong H Park; Shuling Hu; Hideya Kato; Jae H Lee; Li Zhou; Hongli He; Jae W Lee
Journal:  J Immunol       Date:  2019-08-26       Impact factor: 5.422

4.  Proline-Glycine-Proline Peptides Are Critical in the Development of Smoke-induced Emphysema.

Authors:  Mojtaba Abdul Roda; Xin Xu; Tarek H Abdalla; Mariam Sadik; Tomasz Szul; Preston E Bratcher; Liliana Viera; George M Solomon; J Michael Wells; Carmel M McNicholas; Frank A Redegeld; Gert Folkerts; J Edwin Blalock; Amit Gaggar
Journal:  Am J Respir Cell Mol Biol       Date:  2019-11       Impact factor: 6.914

5.  Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.

Authors:  Yeting Du; Monica Ter-Minassian; Lauren Brais; Nichole Brooks; Amanda Waldron; Jennifer A Chan; Xihong Lin; Peter Kraft; David C Christiani; Matthew H Kulke
Journal:  Endocr Relat Cancer       Date:  2016-08       Impact factor: 5.678

6.  The arachidonic acid metabolism protein-protein interaction network and its expression pattern in esophageal diseases.

Authors:  Bingli Wu; Chunying Bai; Zepeng Du; Haiying Zou; Jianyi Wu; Wenming Xie; Pixian Zhang; Liyan Xu; Enmin Li
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

7.  Inflammation-Generated Extracellular Matrix Fragments Drive Lung Metastasis.

Authors:  Sandrine Bekaert; Marianne Fillet; Benoit Detry; Muriel Pichavant; Raphael Marée; Agnes Noel; Natacha Rocks; Didier Cataldo
Journal:  Cancer Growth Metastasis       Date:  2017-12-21

8.  The development of novel LTA4H modulators to selectively target LTB4 generation.

Authors:  Caroline M Low; Samia Akthar; Dhiren F Patel; Stephan Löser; Chi-Tung Wong; Patricia L Jackson; J Edwin Blalock; Stephen A Hare; Clare M Lloyd; Robert J Snelgrove
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

9.  Microbiota and Metatranscriptome Changes Accompanying the Onset of Gingivitis.

Authors:  Emily M Nowicki; Raghav Shroff; Jacqueline A Singleton; Diane E Renaud; Debra Wallace; Julie Drury; Jolene Zirnheld; Brock Colleti; Andrew D Ellington; Richard J Lamont; David A Scott; Marvin Whiteley
Journal:  mBio       Date:  2018-04-17       Impact factor: 7.867

10.  Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.

Authors:  Samia Akthar; Dhiren F Patel; Rebecca C Beale; Teresa Peiró; Xin Xu; Amit Gaggar; Patricia L Jackson; J Edwin Blalock; Clare M Lloyd; Robert J Snelgrove
Journal:  Nat Commun       Date:  2015-09-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.